The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2020
Filed:
Jan. 13, 2020
Applicant:
Chemocentryx, Inc., Mountain View, CA (US);
Inventors:
Thomas Schall, Mountain View, CA (US);
James J. Campbell, San Jose, CA (US);
Assignee:
ChemoCentryx, Inc., Mountain View, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/04 (2006.01); A61K 31/44 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61P 1/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/44 (2013.01); A61P 1/00 (2018.01); C07K 16/2875 (2013.01); A61K 2039/505 (2013.01); C07K 2317/76 (2013.01);
Abstract
Provided herein are compositions, methods and kits for treating inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis in a mammal in need thereof. The method include administering to a subject with IBD a combination therapy containing a therapeutically effective amount of a chemokine receptor 9 (CCR9) inhibitor compound and a therapeutically effective amount of an anti-TNFα antibody. Also provided herein is a kit containing the CCR9 inhibitor compound and anti-TNFα antibody.